Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients (SORT-OUTIII)

Evald Hoej Christiansen

Status and phase: Completed; Phase 3

Conditions: Ischemic Heart Disease

Treatments: Device: Endeavor; Device: Cypher Select

Study type: Interventional

Funder types: Other

Identifiers

NCT00660478

20050194

Details and patient eligibility

About

Randomized clinical comparison of the serolimus eluting Cypher stent and the zotarolimus eluting Endeavor stent.

Enrollment: 2,342 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients treated with one or more drug eluting stents in the coronary arteries at one of the 5 heart centers in Denmark can be included in the study.

Exclusion criteria

• The patient will not participate
• The patient participates in other randomized stent studies
• Expected survival < 1 year
• Allergy to Aspirin, Clopidogrel or Ticlopidine
• Allergy to Sirolimus or ABT-578

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

2,342 participants in 2 patient groups

1

Active Comparator group

Description:

Zotarolimus eluting stent

Treatment:

Device: Endeavor

2

Active Comparator group

Description:

Sirolimus stent

Treatment:

Device: Cypher Select